Gene · 2285
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional and genomic characterization of patient-derived xenograft model to study the adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma. | Cancer Med | 2021 | 33107222 | PubTator, text mining | PubMed |
| Receptor binding competition: A paradigm for regulating TGF-β family action. | Cytokine Growth Factor Rev | 2021 | 33087301 | PubTator, text mining | PubMed |
| Visualizing functional dynamicity in the DNA-dependent protein kinase holoenzyme DNA-PK complex by integrating SAXS with cryo-EM. | Prog Biophys Mol Biol | 2021 | 32966823 | PubTator, text mining | PubMed |
| Galectin-Glycan Interactions: Guidelines for Monitoring by 77 Se NMR Spectroscopy, and Solvent (H2 O/D2 O) Impact on Binding. | Chemistry | 2021 | 32955737 | PubTator, text mining | PubMed |
| Corneal xenotransplantation: Where are we standing? | Prog Retin Eye Res | 2021 | 32755676 | PubTator, text mining | PubMed |
| Turning liabilities into opportunities: Off-target based drug repurposing in cancer. | Semin Cancer Biol | 2021 | 32044472 | PubTator, text mining | PubMed |
| Regulation of cellular anabolism by mTOR: or how I learned to stop worrying and love translation. | Sports Med Health Sci | 2020 | 35782997 | PubTator, text mining | PubMed |
| Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs. | RSC Adv | 2020 | 35746919 | PubTator, text mining | PubMed |
| Antitumor activity and safety of sirolimus for solid tumors with PIK3CA mutations: A multicenter, open-label, prospective single-arm study (KM 02-01, KCSG UN17-16). | Transl Cancer Res | 2020 | 35117688 | PubTator, text mining | PubMed |
| The chemical biology of IL-12 production via the non-canonical NFkB pathway. | RSC Chem Biol | 2020 | 34458756 | PubTator, text mining | PubMed |
| Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells. | Front Bioeng Biotechnol | 2020 | 33718332 | PubTator, text mining | PubMed |
| Cell Populations Expressing Stemness-Associated Markers in Vascular Anomalies. | Front Surg | 2020 | 33634164 | PubTator, text mining | PubMed |
| mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms. | Front Oncol | 2020 | 33628728 | PubTator, text mining | PubMed |
| The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside. | Front Oncol | 2020 | 33489922 | PubTator, text mining | PubMed |
| Current Preventions and Treatments of aGVHD: From Pharmacological Prophylaxis to Innovative Therapies. | Front Immunol | 2020 | 33391276 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects. | Int J Mol Sci | 2020 | 33375317 | PubTator, text mining | PubMed |
| Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide. | Cancers (Basel) | 2020 | 33371210 | PubTator, text mining | PubMed |
| Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing. | Pharmaceutics | 2020 | 33353099 | PubTator, text mining | PubMed |
| K63-linked ubiquitylation induces global sequestration of mitochondria. | Sci Rep | 2020 | 33339882 | PubTator, text mining | PubMed |
| The Potential of Proteolytic Chimeras as Pharmacological Tools and Therapeutic Agents. | Molecules | 2020 | 33339292 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2285/papers?page=34